Because AML FLT3-ITD cells are known to require autophagy, the inhibition of FLT3-ITD cells by FLT3 TKI decrease the disease level strongly enough to reach complete remission, then allowing autophagy to be blocked. Here, FLT3 is linked to acute myeloid leukemia.